injectable glp 1 agonists GLP-1 Medications: Everything You Need to Know How GLP-1 medications are transforming
Description
These differences may also explain differences in gastrointestinal adverse reactions, such as nausea and vomiting, which are common with GLP-1RAs but typically diminish over time [127, 128]
Resolution of steatohepatitis and fibrosis reduction occurred in 32.7% of semaglutide-treated patients versus 16.1% in the placebo group (estimated difference 16.5 percentage points, 95% CI 10.222.8)
doi: 10.1055/s-0042-101794
Timothy Garvey, MD, professor of medicine and director of the University of Alabama at Birminghams Diabetes Research Center
